Dr. Peter Harf is an Executive Chairman at Coty, Inc., a Chairman at Deutsche Stiftung Leben Spenden, a Chairman & Managing Partner at JAB Holding Co. LLC, a Chairman & Chief Executive Officer at Joh. A. Benckiser GmbH, a Chairman & Managing Partner at JAB Holding Co. SARL, a Chairman at Bally International AG, a Chairman at Bally UK Sales Ltd., a Chairman at Coty Italia Srl, a Chairman-Management Board at JAB Luxury GmbH, a Chief Executive Officer at Parentes SE, an Executive Chairman at Delete Blood Cancer, a Managing Director at Agnaten SE and a Managing Director at Lucresca SE.
He is on the Board of Directors at Keurig Dr Pepper, Inc., DKMS Foundation, JAB Holdings BV, Jacobs Douwe Egberts NL BV, Koninklijke Douwe Egberts BV, Peet's Coffee & Tea, Inc., Veterinary Specialists of North America Holdings LLC, Veterinary Specialists of North America LLC, Acorn Holdings BV and JDE Peet's NV. Dr. Harf was previously employed as a Non-Executive Chairman by Jimmy Choo Plc, a Non-Executive Director by D.E. Master Blenders 1753 BV, an Executive Chairman by DKMS gemeinnützige GmbH, a Deputy Chairman by Reckitt Benckiser Group Plc, a Senior Vice President-Corporate Planning by AEG AG, a Chairman by Newbelco SA, a Chairman by Belstaff Group SA, a Chief Executive Officer by Donata Holding SE, a Chairman by Espresso House Holding AB, a Chairman by Espresso House Sweden AB, a Chief Executive Officer by JAB Holdings II BV, and a Principal by The Boston Consulting Group, Inc.
He also served on the board at Maple Parent Holdings Corp., Caribou Coffee Co., Inc., Burger King Holdings, Inc., Brunswick Corp., Einstein Noah Restaurant Group, Inc., Keurig Green Mountain, Inc., Krispy Kreme Doughnuts, Inc., Panera Bread Co., Panera Holdings Corp. and Pret A Manger Ltd.
He received his MBA from Harvard Business School and a doctorate degree from Universität zu Köln.